WebEvofem Biosciences is revolutionizing women’s sexual and reproductive healthcare with a first-in-class innovative hormone-free contraceptive. Evofem’s mission is to empower … About Us - Evofem Biosciences, Inc. (EVFM) - Company Information and … Phexxi ® (lactic acid, citric acid and potassium bitartrate) vaginal gel … Evofem Biosciences’ first commercial product, Phexxi, was recently approved … Clinical Trials - Evofem Biosciences, Inc. (EVFM) - Company Information and … Media Contact - Evofem Biosciences, Inc. (EVFM) - Company Information and … 12400 High Bluff Drive Suite 600 San Diego, California 92130 Phone … Tony O’Brien. Mr. O’Brien has served as a member of the Evofem Biosciences … Together our team launched the first vaginal pH modulator, a unique … WebApr 12, 2024 · — Improves Phexxi coverage for more than 5.8 million New York lives — — Year-to-date, Evofem has gained Phexxi coverage for more than 22.1 million new lives —. SAN DIEGO , April 12, 2024 /PRNewswire/ -- Evofem Biosciences, Inc., (OTCQB: EVFM) today announced a major new win in New York state that improves coverage for Phexxi® …

Evofem Announces Closing of Merger With Neothetics

WebEvofem Biosciences, Inc., (NASDAQ: EVFM) is developing and commercializing innovative products and product candidates to address unmet needs in women’s sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). Evofem’s sole purpose is to improve ... WebApr 14, 2024 · SAN DIEGO , April 14, 2024 /PRNewswire/ --Evofem Biosciences, Inc., (OTCQB: EVFM), the maker of Phexxi® (lactic acid, citric acid and potassium bitartrate), today announced the appointment of Ivy Zhang as Chief Financial Officer (CFO) and Secretary, effective April 13, 2024.Reporting to Chief Executive Officer Saundra Pelletier, … christian bahena rivera family

Careers - Evofem Biosciences, Inc.

WebAug 4, 2024 · Stifel Downgrades Evofem Biosciences to Hold From Buy, Adjusts Price Target to $0.50 Fr.. MT. 2024. HC Wainwright Adjusts Price Target on Evofem Biosciences to $4 From $2, Reiterates Buy .. MT. 2024. Morgan Stanley Adjusts Price Target for Evofem Biosciences to $0.75 From $2, Maintains .. MT. More recommendations. WebSupport: 888-992-3836 Home NewsWire Subscriptions ... WebJan 18, 2024 · However, while Evofem may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing Evofem's views as of any date subsequent to the date hereof. Evofem Biosciences Contact: Marcy Graham … christian bahnson